TV personality Jessel Taank, Olympic gold medalist Tara Lipinski and reproductive endocrinologist Dr. Lucky Sekhon join Ferring to highlight the power of community and story sharing for aspiring ...

Commitment to sustainability demonstrated by SBTi approval of our targets to reduce greenhouse gas emissions, and by our programme to reduce maternal deaths in low- and lower middle-income countries ...

Ferring Global Fertility Monitor will gather data from a representative sample in 70 countries as a part of the Gallup World Poll Consultation to gather expert opinion on high impact questions begins ...

SAINT-PREX, Switzerland--(BUSINESS WIRE)--Ferring Pharmaceuticals today announced that Michel Pettigrew, President of the Executive Board and Chief Operating Officer, will retire from his operational ...

While Ferring is looking at several different models, manufacturing of the gene therapy Adstiladrin is expected to hit full capacity by 2025. (Ferring Pharmaceuticals) After securing approval at the ...

SAINT-PREX, Switzerland--(BUSINESS WIRE)--Ferring Pharmaceuticals announced today that Frederik Paulsen is stepping down from his role as Chairman of the Board of Directors* and transitioning to the ...

Ferring Pharmaceuticals and Posterity Health, a male fertility center of excellence, have partnered to launch a male fertility program. The two organizations announced the program’s debut on Thursday ...

Add Yahoo as a preferred source to see more of our stories on Google. Signage is seen outside of FDA headquarters in White Oak, Maryland (Reuters) -The U.S. Food and Drug Administration on Friday ...

The overall goal of the initiative is to make the entire fertility journey more equitable for both women and men, which, according to Ferring, may ultimately help “improve drop-out rates, decrease ...

Ferring Pharmaceuticals has acquired exclusive licensing rights to the Phase III radicular leg pain candidate SI-6603 (condoliase) from Seikagaku, the companies said today. Seikagaku said the deal ...

Insider obtained a memo Ferring Pharmaceuticals sent to healthcare providers. The company said in the memo that it is "working to address any disruptions to supply." Ferring Pharmaceuticals has ...